Evidence map›Paper›PMID 42143299›Full record

ArticleBMC nephrology2026

Kidney biopsy analysis of 14 cases of renal disease after unrelated cord blood transplantation.

Masato Mizuta, Naoki Sawa, Tatsuya Suwabe, Yuki Oba, Akinari Sekine, Masayuki Yamanouchi, Hiroki Mizuno, Noriko Inoue, Kiho Tanaka, Eiko Hasegawa and 9 more

Erratum issuedAbstract read
In one paragraph

Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Masato MizutaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan. mamoyou12@gmail.com.
Naoki SawaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Tatsuya SuwabeNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Yuki ObaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Akinari SekineNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Masayuki YamanouchiNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Hiroki MizunoNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Noriko InoueNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Kiho TanakaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Eiko HasegawaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Atsushi WakeDepartment of Hematology, Toranomon Hospital, Tokyo, Japan.
Junichi HoshinoNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Kei KonoDepartment of Pathology, Toranomon Hospital, Tokyo, Japan.
Kenichi OhashiDepartment of Pathology, Toranomon Hospital, Tokyo, Japan.
Yutaka YamaguchiYamaguchi's Pathology Laboratory, Chiba, Japan.
Makoto FukudaDepartment of Nephrology, Saga University Internal Medicine, Saga, Japan.
Motoaki MiyazonoDepartment of Nephrology, Saga University Internal Medicine, Saga, Japan.
Takehiko WadaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
Yoshifumi UbaraNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate kidney biopsy findings to clarify renal disease in patients after hematopoietic stem cell transplantation (HSCT) using unrelated umbilical cord blood transplantation (UCBT).

methodsWe retrospectively examined 14 patients who underwent UCBT at Toranomon Hospital, Tokyo, Japan, from 2015 to 2023 and subsequently developed kidney injury requiring biopsy.

resultsAt biopsy, median urinary protein was 0.57 g/day (IQR, 0.27-1.67), median serum creatinine was 1.97 mg/dL (IQR, 1.81-2.6), and median eGFR was 25.3 mL/min/1.73 m

conclusionThe coexistence of glomerular, vascular, and tubulointerstitial microangiopathic lesions was associated with mild proteinuria and renal dysfunction after UCBT. These findings suggest a chronic endothelial injury process distinct from classical thrombotic microangiopathy.

Indexed as

Cord Blood Stem Cell TransplantationKidneyKidney DiseasesAdultBiopsyFemaleHumansMaleMiddle AgedRetrospective StudiesThrombotic MicroangiopathiesBone marrow transplantation (BMT)Chronic kidney disease (CKD)Hematopoietic stem cell transplantation (HSCT)Peripheral blood hematopoietic cell transplantation (PBHCT)Peripheral blood stem cell transplantation (PBSCT)Unrelated cord blood transplantation (UCBT)

Identifiers

PMID42143299
PMCPMC13361586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.